TEVA logo

TEVA Selling, general & administrative expenses

annual SGA:

$3.70B+$204.00M(+5.83%)
December 31, 2024

Summary

  • As of today (September 17, 2025), TEVA annual SGA is $3.70 billion, with the most recent change of +$204.00 million (+5.83%) on December 31, 2024.
  • During the last 3 years, TEVA annual SGA has risen by +$174.00 million (+4.93%).
  • TEVA annual SGA is now -30.40% below its all-time high of $5.32 billion, reached on December 31, 2013.

Performance

TEVA SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

quarterly SGA:

$0.00-$919.00M(-100.00%)
June 30, 2025

Summary

  • As of today (September 17, 2025), TEVA quarterly SGA is $0.00, with the most recent change of -$919.00 million (-100.00%) on June 30, 2025.
  • Over the past year, TEVA quarterly SGA has dropped by -$939.00 million (-100.00%).
  • TEVA quarterly SGA is now -100.00% below its all-time high of $1.48 billion, reached on December 31, 2013.

Performance

TEVA quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

TTM SGA:

-$59.76B-$157.19M(-0.26%)
June 30, 2025

Summary

  • As of today (September 17, 2025), TEVA TTM SGA is -$59.76 billion, with the most recent change of -$157.19 million (-0.26%) on June 30, 2025.
  • Over the past year, TEVA TTM SGA has dropped by -$63.33 billion (-1774.04%).
  • TEVA TTM SGA is now -199.70% below its all-time high of $59.94 billion.

Performance

TEVA TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

TEVA Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.8%-100.0%-1774.0%
3 y3 years+4.9%-100.0%-1768.0%
5 y5 years-2.7%-100.0%-1723.1%

TEVA Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+7.5%-100.0%at low-77.5%at low
5 y5-year-2.7%+7.5%-100.0%at low-116.1%at low
alltimeall time-30.4%>+9999.0%-100.0%at low-199.7%at low

TEVA Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$0.00(-100.0%)
$1.84B(-33.8%)
Mar 2025
-
$919.00M(>+9900.0%)
$2.78B(+1.2%)
Dec 2024
$3.70B(+5.8%)
$0.00(-100.0%)
$2.75B(-24.7%)
Sep 2024
-
$924.00M(-1.6%)
$3.65B(+2.2%)
Jun 2024
-
$939.00M(+6.0%)
$3.57B(+0.8%)
Mar 2024
-
$886.00M(-1.7%)
$3.54B(+1.3%)
Dec 2023
$3.50B(+1.5%)
$901.00M(+6.8%)
$3.50B(+1.8%)
Sep 2023
-
$844.00M(-7.3%)
$3.43B(+0.6%)
Jun 2023
-
$910.00M(+8.1%)
$3.41B(+0.1%)
Mar 2023
-
$842.00M(+0.5%)
$3.41B(-1.1%)
Dec 2022
$3.44B(-2.4%)
$838.00M(+1.9%)
$3.45B(-2.0%)
Sep 2022
-
$822.00M(-9.4%)
$3.52B(-1.8%)
Jun 2022
-
$907.00M(+3.1%)
$3.58B(+1.4%)
Mar 2022
-
$880.00M(-3.1%)
$3.53B(+0.1%)
Dec 2021
$3.53B(-3.9%)
$908.00M(+2.3%)
$3.53B(-2.8%)
Sep 2021
-
$888.00M(+3.6%)
$3.63B(+0.1%)
Jun 2021
-
$857.00M(-2.1%)
$3.63B(-0.1%)
Mar 2021
-
$875.00M(-13.4%)
$3.63B(-1.1%)
Dec 2020
$3.67B(-3.5%)
$1.01B(+14.3%)
$3.67B(-0.4%)
Sep 2020
-
$884.00M(+2.7%)
$3.69B(+0.1%)
Jun 2020
-
$861.00M(-6.1%)
$3.68B(-2.7%)
Mar 2020
-
$917.00M(-10.4%)
$3.78B(-0.6%)
Dec 2019
$3.81B(-9.7%)
$1.02B(+16.4%)
$3.81B(-3.0%)
Sep 2019
-
$880.00M(-8.5%)
$3.92B(-4.2%)
Jun 2019
-
$962.00M(+2.3%)
$4.09B(-0.9%)
Mar 2019
-
$940.00M(-17.6%)
$4.13B(-3.0%)
Dec 2018
$4.21B(-13.0%)
$1.14B(+8.5%)
$4.26B(+3.4%)
Sep 2018
-
$1.05B(+5.4%)
$4.12B(-3.8%)
Jun 2018
-
$998.00M(-6.5%)
$4.28B(-6.7%)
Mar 2018
-
$1.07B(+6.7%)
$4.59B(-5.3%)
Dec 2017
$4.85B(-2.6%)
$1.00B(-17.7%)
$4.85B(-8.3%)
Sep 2017
-
$1.22B(-7.0%)
$5.29B(-0.7%)
Jun 2017
-
$1.31B(-1.3%)
$5.32B(+0.8%)
Mar 2017
-
$1.32B(-8.1%)
$5.28B(+3.6%)
Dec 2016
$4.97B(+2.8%)
$1.44B(+15.2%)
$5.10B(+4.8%)
Sep 2016
-
$1.25B(-1.0%)
$4.86B(+3.3%)
Jun 2016
-
$1.26B(+10.5%)
$4.71B(+1.7%)
Mar 2016
-
$1.14B(-5.3%)
$4.63B(-1.8%)
Dec 2015
$4.84B(-4.7%)
$1.21B(+10.1%)
$4.72B(-2.5%)
Sep 2015
-
$1.10B(-7.5%)
$4.84B(-3.0%)
Jun 2015
-
$1.19B(-3.6%)
$4.98B(-0.9%)
Mar 2015
-
$1.23B(-7.3%)
$5.03B(-1.1%)
Dec 2014
$5.08B(-4.5%)
$1.33B(+6.7%)
$5.08B(-3.0%)
Sep 2014
-
$1.24B(+1.2%)
$5.24B(-1.2%)
Jun 2014
-
$1.23B(-4.5%)
$5.30B(-2.4%)
Mar 2014
-
$1.29B(-13.3%)
$5.43B(-1.0%)
Dec 2013
$5.32B(+3.9%)
$1.48B(+13.5%)
$5.49B(+2.0%)
Sep 2013
-
$1.31B(-3.7%)
$5.38B(+2.8%)
Jun 2013
-
$1.36B(+1.0%)
$5.23B(+1.8%)
Mar 2013
-
$1.34B(-2.3%)
$5.13B(+3.1%)
Dec 2012
$5.12B(+16.0%)
$1.37B(+18.6%)
$4.98B(+1.7%)
Sep 2012
-
$1.16B(-8.3%)
$4.90B(+5.3%)
Jun 2012
-
$1.26B(+6.4%)
$4.65B(+2.9%)
Mar 2012
-
$1.19B(-8.2%)
$4.52B(+2.5%)
Dec 2011
$4.41B(+15.1%)
$1.29B(+41.6%)
$4.41B(+5.1%)
Sep 2011
-
$911.90M(-19.3%)
$4.20B(-1.4%)
Jun 2011
-
$1.13B(+5.0%)
$4.26B(+7.3%)
Mar 2011
-
$1.08B(-0.2%)
$3.97B(+3.7%)
Dec 2010
$3.83B
$1.08B(+10.8%)
$3.83B(+2.3%)
DateAnnualQuarterlyTTM
Sep 2010
-
$973.26M(+15.7%)
$3.74B(+2.7%)
Jun 2010
-
$840.98M(-9.9%)
$3.64B(+0.2%)
Mar 2010
-
$933.25M(-6.0%)
$3.63B(+3.4%)
Dec 2009
$3.50B(+39.3%)
$992.62M(+13.6%)
$3.51B(+9.6%)
Sep 2009
-
$873.56M(+5.0%)
$3.21B(+7.4%)
Jun 2009
-
$832.23M(+2.1%)
$2.99B(+6.4%)
Mar 2009
-
$815.10M(+18.8%)
$2.81B(+12.2%)
Dec 2008
$2.51B(+32.1%)
$685.82M(+5.0%)
$2.50B(+6.4%)
Sep 2008
-
$653.09M(-0.0%)
$2.35B(+9.1%)
Jun 2008
-
$653.36M(+27.9%)
$2.16B(+8.5%)
Mar 2008
-
$510.72M(-4.8%)
$1.99B(+2.9%)
Dec 2007
$1.90B(+20.9%)
$536.36M(+17.4%)
$1.93B(+3.3%)
Sep 2007
-
$457.04M(-5.8%)
$1.87B(+3.1%)
Jun 2007
-
$485.15M(+6.6%)
$1.82B(+6.6%)
Mar 2007
-
$455.27M(-4.2%)
$1.70B(+36.4%)
Dec 2006
$1.57B(+96.7%)
$475.31M(+18.6%)
$1.25B(+61.4%)
Sep 2006
-
$400.77M(+7.3%)
$774.13M(+107.3%)
Jun 2006
-
$373.36M(>+9900.0%)
$373.36M(>+9900.0%)
Mar 2006
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2005
$799.00M(+14.6%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2005
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2005
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2005
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2004
$697.00M(+33.9%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2004
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2004
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2004
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2003
$520.60M(+28.1%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2003
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2003
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2003
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2002
$406.40M(+11.8%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2002
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2002
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2002
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2001
$363.56M(+18.4%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2001
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2001
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2001
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2000
$307.08M(+31.3%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2000
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2000
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1999
$233.89M(+12.4%)
-
-
Dec 1998
$208.00M(+5.6%)
-
-
Sep 1998
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1998
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1998
-
$0.00
$0.00
Dec 1997
$197.00M(+17.5%)
-
-
Dec 1996
$167.60M(+15.3%)
-
-
Dec 1995
$145.40M(+12.1%)
-
-
Dec 1994
$129.70M(+28.2%)
-
-
Dec 1993
$101.20M(+22.7%)
-
-
Dec 1992
$82.50M(+23.0%)
-
-
Dec 1991
$67.10M(-20.9%)
-
-
Dec 1990
$84.80M(+51.2%)
-
-
Dec 1989
$56.10M(+9.4%)
-
-
Dec 1988
$51.30M(+69.3%)
-
-
Mar 1987
$30.30M(+78.2%)
-
-
Mar 1986
$17.00M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual SGA?
  • What is the all time high annual SGA for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual SGA year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly SGA?
  • What is the all time high quarterly SGA for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly SGA year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM SGA?
  • What is the all time high TTM SGA for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM SGA year-on-year change?

What is Teva Pharmaceutical Industries Limited annual SGA?

The current annual SGA of TEVA is $3.70B

What is the all time high annual SGA for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual SGA is $5.32B

What is Teva Pharmaceutical Industries Limited annual SGA year-on-year change?

Over the past year, TEVA annual SGA has changed by +$204.00M (+5.83%)

What is Teva Pharmaceutical Industries Limited quarterly SGA?

The current quarterly SGA of TEVA is $0.00

What is the all time high quarterly SGA for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly SGA is $1.48B

What is Teva Pharmaceutical Industries Limited quarterly SGA year-on-year change?

Over the past year, TEVA quarterly SGA has changed by -$939.00M (-100.00%)

What is Teva Pharmaceutical Industries Limited TTM SGA?

The current TTM SGA of TEVA is -$59.76B

What is the all time high TTM SGA for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM SGA is $59.94B

What is Teva Pharmaceutical Industries Limited TTM SGA year-on-year change?

Over the past year, TEVA TTM SGA has changed by -$63.33B (-1774.04%)
On this page